Information about Jalima Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0824.690.634

VAT liability
Yes
Established
31-03-2010
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Jalima Pharma

2024 2023 2022 2021
Profit/Loss 32,116 105 % 15,661 128 % -55,444 -146 % 120,076
Equity 291,397 3 % 284,282 6 % 268,621 -35 % 413,341
Gross margin -18,827 -271 % 11,003 -60 % 27,504 -61 % 70,082

Publications from Jalima Pharma

Date Publication
09-05-2025 Resignations - Appointments (NL)
05-08-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form (NL)
02-05-2018 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
08-04-2014 Capital - Shares (NL)
01-12-2010 Capital - Shares (NL)

Frequently asked questions

What is the VAT number of Jalima Pharma?
The VAT number of Jalima Pharma is BE 0824.690.634.
Wat is the PEPPOL ID of Jalima Pharma?
The PEPPOL ID of Jalima Pharma is 0208:0824690634. Log in or start a free trial to see the full overview.
When was Jalima Pharma founded?
Jalima Pharma was founded on 31-03-2010.
What is the address of Jalima Pharma?
The current registered office of Jalima Pharma is located at Jozef Van Walleghemstraat 11, 8200 Brugge.
When was the last time Jalima Pharma filed their annual financial statements?
The most recent financial statements of Jalima Pharma were filed on 17-01-2025.
How many employees does Jalima Pharma have?
There are currently no employees working at Jalima Pharma or no workforce information is available.
What is the annual turnover of Jalima Pharma?
At the time of its most recent financial statements, Jalima Pharma did not publish any turnover figures. Jalima Pharma reported a gross margin of -€18,826.94.